Interleukin-based anti-metastasis therapy: Interleukin-1β (IL-1β) inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3, 23/March/2015, 12.48 pm

Therapeutic insights into the treatment of Stress-induced heart failure: OncoMiR-17-92 protects against stress-induced heart failure via up regulation of SNX13, 23/March/2015, 9.17 am
March 23, 2015
Life-span extension therapy: LIF inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 23/March/2014, 15.05
March 23, 2015
Show all

A recent study from the Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne 1015, Switzerland shows that GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.” This study was published in the 29 July  2014 issue of the Journal “Cell Metabolism” (the no.1 journal in Metabolism; and I.F: 16.747) by Prof. Etienne Meylan, Masin M and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Interleukin-based anti-metastasis therapy: Interleukin-1β (IL-1β) inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3.

Significance:  The study presented here suggests, for the first time, that IL-1β, by increasing the expression of its target gene, it may decrease the expression of GLUT3. Thereby, it may inhibit glycolysis. Thus, pharmacological formulations encompassing ” IL-1β activators” may be used to stall the progression of invasive human tumors.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

CitationBoominathan, Interleukin-based anti-metastasis therapy: Interleukin-1β (IL-1β) inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3, 23/March/2015, 12.48 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Interleukin-1β (IL-1β) suppresses the expression of GLUT3

* Research cooperation

Comments are closed.